Elekta (OTCMKTS:EKTAY) Sees Large Volume Increase – Here’s Why

Shares of Elekta AB (OTCMKTS:EKTAY) saw unusually-high trading volume on Friday . 3,728 shares were traded during mid-day trading, an increase of 26% from the previous session’s volume of 2,960 shares.The stock last traded at $5.57 and had previously closed at $5.4150.

Wall Street Analysts Forecast Growth

Separately, Zacks Research upgraded shares of Elekta from a “strong sell” rating to a “hold” rating in a report on Tuesday, July 28th. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Reduce”.

Elekta Trading Up 2.9%

The firm has a market cap of $2.05 billion, a price-to-earnings ratio of -34.81 and a beta of 1.01. The company has a debt-to-equity ratio of 0.47, a current ratio of 0.87 and a quick ratio of 0.68. The business has a 50-day moving average of $5.14 and a 200-day moving average of $5.75.

Elekta (OTCMKTS:EKTAY) last posted its quarterly earnings results on Thursday, May 28th. The company reported $0.06 earnings per share for the quarter. Elekta had a positive return on equity of 11.11% and a negative net margin of 3.32%.The firm had revenue of $521.00 million during the quarter. Research analysts anticipate that Elekta AB will post 0.43 EPS for the current year.

Elekta Company Profile

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.